![](/img/cover-not-exists.png)
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
Natasha K. Martin, Peter Vickerman, Graham R. Foster, Sharon J. Hutchinson, David J. Goldberg, Matthew HickmanVolume:
54
Year:
2011
Language:
english
DOI:
10.1016/j.jhep.2010.08.029
File:
PDF, 4.40 MB
english, 2011